Physician profile
Ian Patten
NPI 1699153601
$49,563.18
in general payments reported to CMS, 2019-2025
12 companies · $601 in 2025
The $601 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.62 · 2020: $30K · 2021: $16K · 2022: $107 · 2023: $1,928 · 2024: $108 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,814 · Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,814.02 |
| Food and Beverage | $822.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,858.64 | 2020-2025 | |
| Micromed INC | $19,823.50 | 2020-2021 | |
| Smith+Nephew, INC. | $4,926.04 | 2020-2023 | Acufex Meniscal Root Repair |
| Kairos Surgical INC | $2,534.94 | 2021-2024 | |
| Stryker Corporation | $798.84 | 2020-2022 | |
| Carbofix Spine INC | $266.07 | 2023 | |
| Miach Orthopaedics, INC. | $123.55 | 2023 | |
| Vericel Corporation | $107.04 | 2022-2024 | Maci |
| Innovation Technologies INC | $62.50 | 2021 | |
| Supreme Orthopedic Systems, LLC | $35.62 | 2019 | |
| Depuy Synthes Sales INC. | $13.68 | 2020 | |
| Zimmer Biomet Holdings, INC. | $12.76 | 2023 | Juggerknotless Soft Anchor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Patten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.